Gene · 23524
SRRM2: serine/arginine repetitive matrix 2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SRRM2: serine/arginine repetitive matrix 2. Genes, record 23524. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23524
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9UQ35 | Serine/arginine repetitive matrix protein 2 | 2,752 | 25 | Ensembl, GeneID, HGNC |
Source UniProt
Patents29
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2026190091 A1 | 2026-09-17 | 8 | Q9UQ35 | Espacenet |
| WO 2026167106 A1 | 2026-08-13 | 12 | Q9UQ35 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 63065 | Q9UQ35 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4098 | Q9UQ35 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 534 | Q9UQ35 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 3655 | Q9UQ35 | Espacenet |
| US 12433888 B1 | 2025-10-07 | 10 | Q9UQ35 | Espacenet |
| KR 1020250099050 A | 2025-07-01 | 25 | Q9UQ35 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 534 | Q9UQ35 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 3655 | Q9UQ35 | Espacenet |
1 to 10 of 29
See all 29 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,222
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SRRM2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| ZIAAG000393 | Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 3 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 3 | 2025 |
| ZIAAG000511 | Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis | 3 | 2025 |
| P01CA022443 | Molecular Biology and Genetics of Human Tumor Viruses | 2 | 2025 |
| P01CA092584 | Structural Cell Biology of DNA Repair Machines | 2 | 2025 |
| P01CA100730 | Retrovirus Models of Cancer | 2 | 2025 |
| P01CA120964 | Molecular Pathogenesis of the Hamartoma Syndromes | 2 | 2025 |
1 to 10 of 1,222Source NIH's project files
See all 1,222 nih grantsPapers1,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gut Microbiota-Elicited Aberrant Phosphorylation Induces Protein Structural Anomalies: A Non-Negligible Pathogenic Driver of Autism Spectrum Disorder. | Microorganisms | 2026 | 42795509 | PubTator, text mining | PubMed |
| Seizures in SRRM2-related disorder and treatment response. | Eur J Paediatr Neurol | 2026 | 42785215 | PubTator, text mining | PubMed |
| Serine/Arginine-Protein Kinase 1 Co-Phosphorylation Signatures Uncover Splicing-Driven Mechanisms in Oncogenic Pathway Modulation. | OMICS | 2026 | 42781926 | PubTator, text mining | PubMed |
| Nuclear speckle-associated perispeckle networks partition active chromatin into gene expression niches. | Cell Rep | 2026 | 42603274 | PubTator, text mining | PubMed |
| The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages. | NPJ Precis Oncol | 2026 | 42601376 | PubTator, text mining | PubMed |
| Hiding in Plain Sight: HIV-1 Membraneless Organelles as Nuclear Hubs-Host Hijacking, Replication, Immune Evasion, and Drug-Access Implications. | Pathogens | 2026 | 42515093 | PubTator, text mining | PubMed |
| Oxidative modification alters tau condensation and promotes tau-associated cytoplasmic speckle formation. | J Biol Chem | 2026 | 42497988 | PubTator, text mining | PubMed |
| Global Phosphoproteome Analysis Identifies CLK4 Co-Regulatory Pathways Driving Tumor-Specific Dysregulation. | OMICS | 2026 | 42484065 | PubTator, text mining | PubMed |
| Senescent cells cluster CTCF on nuclear speckles to instruct an alternative splicing program. | Nat Aging | 2026 | 42481807 | PubTator, text mining | PubMed |
| Integrative multi-omics profiling identifies a lactylation-associated, metabolically active, and immunosuppressive subtype of colon adenocarcinoma. | Mol Cell Oncol | 2026 | 42459416 | PubTator, text mining | PubMed |
1 to 10 of 1,431
See all 1,431 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23524
GET https://conductscience.org/api/genes/v1/23524/patents?page=2